By Neil Emerson | GB Practice Leader – Life Sciences at WTW Risk analytics could be a golden opportunity. At first sight, insurance spending looks an unlikely candidate to deliver the additional value that life sciences companies are searching for – at least not without increased hazard. Reducing insurance cover may well result in lower premiums, but it will typically expose the business to additional risk; that may not be something that risk managers are comfortable with.